Csenge Advisory Group Sanofi Transaction History

Csenge Advisory Group

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 04, 2022	BUY	$37.22 - $100.5 $3,647 - $9,849	98 Added 1.81%	5,510 $209,000
Q2 2022 Jul 27, 2022	SELL	$48.99 - $57.46 $97 - $114	-2 Reduced 0.04%	5,412 $271,000
Q1 2022 May 09, 2022	BUY	$48.48 - $53.65 $262,470 - $290,461	5,414 New	5,414 $278,000
Q4 2021 Feb 10, 2022	SELL	$47.07 - $52.35 $254,742 - $283,318	-5,412 Closed	0 $0
Q3 2021 Oct 20, 2021	BUY	$47.89 - $53.12 $259,180 - $287,485	5,412 New	5,412 $259,000
Q3 2020 Nov 09, 2020	SELL	$49.47 - $53.77 $237,653 - $258,311	-4,804 Closed	0 $0
Q2 2020 Jul 17, 2020	SELL	$42.91 - $52.5 $77,109 - $94,342	-1,797 Reduced 27.22%	4,804 $245,000
Q1 2020 Apr 21, 2020	BUY	$38.02 - $51.66 $62,048 - $84,309	1,632 Added 32.84%	6,601 $289,000
Q4 2019 Feb 05, 2020	BUY	$44.25 - $50.86 $2,389 - $2,746	54 Added 1.1%	4,969 $249,000
Q3 2019 Nov 14, 2019	BUY	$40.34 - $46.64 $198,271 - $229,235	4,915 New	4,915 $228,000

822

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $121B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Csenge Advisory Group, based on Form 13F filings with the SEC.

Stay updated on Csenge Advisory Group with notifications on news.